שווי מצרפי של נכסים: seraprognostics.com (SERA)

Sera Prognostics is recognized as an authoritative developer of advanced diagnostics for pregnant women, having earned the trust of physicians by saving the lives of newborns. This chart of total asset price changes, with a value of 99.28, confirms the business's financial foundation. Sera Prognostics possesses strong market influence, offering the exclusive PreTRM blood analysis for predicting preterm birth. The company is currently expanding rapidly, implementing critical tools for the health protection of both mother and fetus.

For Sera Prognostics (SERA), the growth of total resources is critical when scaling proteomic tests through insurance and retail channels. This level of organizational assets is reverse-calculated via return on assets (ROA), which allows for the filtering of market noise to reveal real capital dynamics. The positive trend confirms the expansion of the business's fundamental base; however, stagnant net income amid growing assets signals a risk of declining overall investment efficiency.